Dermapharm Holding SE

DMPGermany

31 filed reports · 191 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

€1.16B

FY2025 · to Dec 31, 2025

down −1.3% vs €1.18B

Annual report

Operating income

€221M

FY2025 · to Dec 31, 2025

up +1.7% vs €217M

Annual report

Latest quarter

Revenue

€285M

Q2 FY2026 · to Jun 30, 2026

Half-year report

Operating income

€71M

Q2 FY2026 · to Jun 30, 2026

Half-year report

Filed reports

31 reports · Sep 2017 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Half YearBundesanzeiger9776Jun 2018 to Jun 2026
Q3Bundesanzeiger9576Sep 2017 to Sep 2025
Q1Bundesanzeiger8587Mar 2019 to Mar 2026
AnnualBundesanzeiger5348Dec 2021 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q2half year2026-06-302026-06-30111Open
FY2026 Q1q12026-03-312026-03-3187Open
FY2025annual2025-12-312025-12-3170Open
FY2025 Q3q32025-09-302025-09-3070Open
FY2025 Q2half year2025-06-302025-06-3045Open
FY2025 Q1q12025-03-312025-03-3169Open
FY2024annual2024-12-312024-12-3171Open
FY2024 Q3q32024-09-302024-09-3072Open
FY2024 Q2half year2024-06-302024-06-3088Open
FY2024 Q1q12024-03-312024-03-3142Open
FY2023annual2023-12-312023-12-3169Open
FY2023 Q3q32023-09-302023-09-3044Open

Financial data

191 concepts · 2,287 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

IFRS179 concepts · 2,086 facts · Sep 2017 to Jun 2026

  • Stockholders Equity45 · Dec 2017 to Jun 2026
  • Operating Income33 · Jun 2018 to Jun 2026
  • Total Assets32 · Sep 2017 to Jun 2026
  • Total Current Assets32 · Dec 2017 to Jun 2026
  • Total Current Liabilities32 · Dec 2017 to Jun 2026
  • Total non-current assets31 · Dec 2017 to Jun 2026
  • Accounts Payable30 · Jun 2018 to Jun 2026
  • Cash and Equivalents30 · Sep 2017 to Jun 2026
  • Current financial liabilities30 · Dec 2017 to Jun 2026
  • Equity investments30 · Jun 2018 to Jun 2026
  • Goodwill30 · Jun 2018 to Jun 2026
  • Intangible Assets (excluding Goodwill)30 · Jun 2018 to Jun 2026
  • Inventory30 · Jun 2018 to Jun 2026
  • Investments accounted for using the equity method30 · Jun 2018 to Jun 2026
  • Non-current financial liabilities30 · Jun 2018 to Jun 2026
  • Other provisions30 · Jun 2018 to Jun 2026
  • Property, Plant & Equipment, Net30 · Jun 2018 to Jun 2026
  • Revenue30 · Jun 2018 to Jun 2026
  • Total non-current liabilities30 · Dec 2017 to Jun 2026
  • Accounts Receivable, Net29 · Jun 2018 to Jun 2026
  • Capital reserves29 · Jun 2018 to Jun 2026
  • Other current financial assets29 · Dec 2017 to Jun 2026
  • Other non-current financial assets29 · Sep 2018 to Jun 2026
  • Deferred tax liabilities28 · Jun 2018 to Jun 2026

Segment9 concepts · 177 facts · Jun 2018 to Jun 2026

  • EBITDA margin37 · Jun 2018 to Jun 2026
  • EBITDA (unadjusted)30 · Jun 2018 to Jun 2026
  • Reported revenue in the “Parallel import business“ segment30 · Jun 2018 to Jun 2026
  • Revenue30 · Jun 2018 to Jun 2026
  • of which intersegment revenue17 · Sep 2018 to Jun 2026
  • of which earnings from investments accounted for using the equity method12 · Sep 2018 to Jun 2026
  • Revenue from external customers9 · Mar 2021 to Mar 2022
  • Cost of materials6 · Mar 2026 to Jun 2026
  • Personnel expenses6 · Mar 2026 to Jun 2026

KPI1 concept · 15 facts · Mar 2021 to Dec 2025

  • Equity ratio15 · Mar 2021 to Dec 2025

APM2 concepts · 9 facts · Jun 2018 to Sep 2020

  • EBITDA8 · Jun 2018 to Sep 2020
  • non-recurring expenses and provisions1 · Sep 2020

Segments

177 facts

Figures broken down by business line, region, product or another axis the company reports on.

Business segment7 members · 177 facts

  • Parallel import business53 · Jun 2018 to Jun 2026
  • Branded pharmaceuticals and other healthcare products50 · Jun 2018 to Mar 2022
  • Herbal extracts37 · Mar 2019 to Mar 2022
  • Branded pharmaceuticals15 · Mar 2026 to Jun 2026
  • Other healthcare products14 · Mar 2026 to Jun 2026
  • Parallel imports4 · Jun 2018
  • Pharmaceuticals and other healthcare products4 · Jun 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Dermapharm Holding SE (DMP) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.